ProCE Banner Activity

CME

Innovations in SLE: Advancing Strategies for Promoting Equality in Care

In this interactive, CME-certified video module, Anca D. Askanase, MD, MPH; David R. Fernandez, MD, PhD; and Jane E. Salmon, MD, provide expert perspectives on SLE diagnosis and management and discuss emerging therapeutics, with a focus on women of color.

Physicians : maximum of 1.25 AMA PRA Category 1 {Credits}

Released: March 13, 2018

Expiration: April 22, 2019

No longer available for credit.

Share

Faculty

Anca D. Askanase

Anca D. Askanase, MD, MPH

Associate Professor of Medicine
Division of Rheumatology
Director, Lupus Center
Columbia University Medical Center
New York, New York

David R. Fernandez

David R. Fernandez, MD, PhD

Assistant Attending Physician
Department of Rheumatology
Hospital for Special Surgery
New York, New York

Chaim Putterman

Chaim Putterman, MD

Professor of Medicine, Microbiology and Immunology
Chief of Rheumatology
Albert Einstein College of Medicine
Bronx, New York

Jane E. Salmon

Jane E. Salmon, MD

Professor 
Division of Rheumatology
Department of Medicine
Hospital for Special Surgery
Weill Cornell College of Medicine
New York, New York

Provided by

Provided by Postgraduate Institute for Medicine
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca Pharmaceuticals LP

GlaxoSmithKline

Target Audience

This program is intended for rheumatologists and other healthcare providers who care for patients with SLE.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Consider SLE in the differential diagnosis in women of color who present with suggestive symptoms and perform appropriate workup to confirm a diagnosis to promptly initiate treatment
  • Develop effective SLE management teams for underserved patients who have limited healthcare resources to improve outcomes in this vulnerable population
  • Explore emerging data from key clinical trials on new therapies and biomarkers for SLE and their significance in minority patient populations while implementing strategies to encourage minority participation in SLE-focused clinical trials

Faculty Disclosure

Primary Author

Anca D. Askanase, MD, MPH

Associate Professor of Medicine
Division of Rheumatology
Director, Lupus Center
Columbia University Medical Center
New York, New York

Anca D. Askanase, MD, MPH, has no real or apparent conflicts of interest to report.

David R. Fernandez, MD, PhD

Assistant Attending Physician
Department of Rheumatology
Hospital for Special Surgery
New York, New York

David R. Fernandez, MD, PhD, has no real or apparent conflicts of interest to report.

Chaim Putterman, MD

Professor of Medicine, Microbiology and Immunology
Chief of Rheumatology
Albert Einstein College of Medicine
Bronx, New York

Chaim Putterman, MD, has no real or apparent conflicts of interest to report.

Jane E. Salmon, MD

Professor 
Division of Rheumatology
Department of Medicine
Hospital for Special Surgery
Weill Cornell College of Medicine
New York, New York

Jane E. Salmon, MD, has no real or apparent conflicts of interest to report.

Staff Disclosure

Staff

Megan K. Murphy, PhD

Scientific Director

Megan K. Murphy, PhD, has no real or apparent conflicts of interest to report.

Jenny Schulz, PhD

Associate Managing Editor, Hepatitis
Clinical Care Options, LLC

Jenny Schulz, PhD, has no real or apparent conflicts of interest to report.

Ryan P. Topping, PhD

Associate Managing Editor

Ryan P. Topping, PhD, has no real or apparent conflicts of interest to report.

Instructions for Credit


Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Clinical Care Options, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Creditâ„¢. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Additional Information

Participation in this self-study activity should be completed in approximately 1.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from March 13, 2018, through April 22, 2019:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


Goal


The goal of this activity is to improve participants’ competence in applying current and emerging treatment strategies in the management of women of color with SLE.